What is the primary physiological process affected by myasthenia gravis?

What is the primary physiological process affected by myasthenia gravis?

• A. Muscle relaxation
• B. Acetylcholine receptor function
• C. Nerve impulse transmission
• D. Calcium reabsorption

Answer: (B)

The primary physiological process affected by myasthenia gravis is acetylcholine receptor function. Myasthenia gravis is an autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of voluntary muscles. In this condition, antibodies are produced that target and block or destroy nicotinic acetylcholine receptors at the neuromuscular junction. This impedes the ability of acetylcholine, a neurotransmitter, to bind to its receptors effectively, thereby disrupting the transmission of nerve signals that stimulate muscle contraction. In essence, acetylcholine normally binds to these receptors to facilitate muscle contraction, and when their function is compromised, it leads to the hallmark symptoms of muscle weakness and fatigue. Thus, understanding the involvement of acetylcholine receptor function provides crucial insights into the pathophysiology of myasthenia gravis and its clinical manifestations.

The primary physiological process affected by myasthenia gravis is acetylcholine receptor function. Myasthenia gravis is an autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of voluntary muscles. In this condition, antibodies are produced that target and block or destroy nicotinic acetylcholine receptors at the neuromuscular junction. This impedes the ability of acetylcholine, a neurotransmitter, to bind to its receptors effectively, thereby disrupting the transmission of nerve signals that stimulate muscle contraction.

In essence, acetylcholine normally binds to these receptors to facilitate muscle contraction, and when their function is compromised, it leads to the hallmark symptoms of muscle weakness and fatigue. Thus, understanding the involvement of acetylcholine receptor function provides crucial insights into the pathophysiology of myasthenia gravis and its clinical manifestations.